News

All Releases
Tandem Diabetes Care Announces Full Repayment of Outstanding CRG Debt
Aug 08, 2018

SAN DIEGO --(BUSINESS WIRE)--Aug. 8, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced that it has fully repaid its term loan made by Capital

Tandem Diabetes Care Announces Publication of PROLOG Study Results in Diabetes Care Journal
Aug 08, 2018

Study Demonstrates Significant Reduction in Hypoglycemia without Rebound Hyperglycemia SAN DIEGO --(BUSINESS WIRE)--Aug. 8, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM)

Tandem Diabetes Care Announces Closing of $115 Million Underwritten Public Offering of Common Stock
Aug 07, 2018

SAN DIEGO --(BUSINESS WIRE)--Aug. 7, 2018-- Tandem Diabetes Care ® , Inc. (NASDAQ: TNDM), (“Tandem”) a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the closing of its previously announced underwritten public offering

Tandem Diabetes Care Announces Pricing of $100 Million Public Offering of Common Stock
Aug 03, 2018

SAN DIEGO --(BUSINESS WIRE)--Aug. 3, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) (“Tandem”), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the pricing of an underwritten public offering of 3,508,770 shares of

Tandem Diabetes Care Announces Proposed Underwritten Public Offering of Common Stock
Aug 02, 2018

SAN DIEGO --(BUSINESS WIRE)--Aug. 2, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) (“Tandem”), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that it has commenced a proposed underwritten public offering of its

Tandem Diabetes Care Reports Second Quarter 2018 Financial Results
Jul 30, 2018

SAN DIEGO --(BUSINESS WIRE)--Jul. 30, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pump available in the United States , today reported its financial results for the quarter ended June 30, 2018 .

Tandem Diabetes Care Schedules Second Quarter 2018 Earnings Press Release and Conference Call
Jul 16, 2018

SAN DIEGO --(BUSINESS WIRE)--Jul. 16, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , plans to release its second quarter 2018 results after the financial markets close on Monday,

Tandem Diabetes Care Announces FDA Approval of t:slim X2 Insulin Pump with Basal-IQ Technology
Jun 21, 2018

New Predictive Low Glucose Suspend Feature to Launch with Dexcom G6 CGM System Integration SAN DIEGO --(BUSINESS WIRE)--Jun. 21, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today

Tandem Diabetes Care to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference
May 09, 2018

SAN DIEGO --(BUSINESS WIRE)--May 9, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that Kim Blickenstaff , president and CEO, will present a company update at the

Tandem Diabetes Care to Present at the Deutsche Bank 43rd Annual Health Care Conference
May 01, 2018

SAN DIEGO --(BUSINESS WIRE)--May 1, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that Kim Blickenstaff , president and CEO, will present a company update at the

Tandem Diabetes Care Receives CE Mark for t:slim X2 Insulin Pump
Apr 30, 2018

SAN DIEGO --(BUSINESS WIRE)--Apr. 30, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps, today announced receipt of CE mark approval for the t:slim X2™ Insulin Pump with Dexcom G5® Mobile continuous glucose monitoring

Tandem Diabetes Care Reports First Quarter 2018 Financial Results
Apr 26, 2018

SAN DIEGO --(BUSINESS WIRE)--Apr. 26, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today reported its financial results for the quarter ended March 31, 2018 .

Tandem Diabetes Care Announces Agreements for Distribution of Insulin Pump Products in Australia and New Zealand
Apr 23, 2018

SAN DIEGO --(BUSINESS WIRE)--Apr. 23, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that it has entered into distribution agreements with Australasian Medical &

Tandem Diabetes Care Schedules First Quarter 2018 Earnings Press Release and Conference Call
Apr 18, 2018

SAN DIEGO --(BUSINESS WIRE)--Apr. 18, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , plans to release its first quarter 2018 results after the financial markets close on Thursday,

Tandem Diabetes Care Announces Preliminary First Quarter 2018 Results
Apr 10, 2018

SAN DIEGO --(BUSINESS WIRE)--Apr. 10, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today reported select, unaudited and preliminary results for the quarter ended March 31, 2018 .

Tandem Diabetes Care and Movi SpA Announce Agreement for Distribution of Insulin Pump Products in Italy
Apr 09, 2018

SAN DIEGO --(BUSINESS WIRE)--Apr. 9, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: tndm), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that it has entered into a distribution agreement with Movi SpA to commercialize

Tandem Diabetes Care Announces Upcoming Conference Presentations
Mar 07, 2018
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that Kim Blickenstaff , president and CEO, will present a company update at the following
Tandem Diabetes Care Announces Upcoming Conference Presentations
Mar 07, 2018
SAN DIEGO --(BUSINESS WIRE)--Mar. 7, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that Kim Blickenstaff , president and CEO, will present a company update at the
Tandem Diabetes Care Announces 2017 Financial Results
Mar 01, 2018
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today reported its financial results for the year and quarter ended December 31, 2017 and financial guidance for
Tandem Diabetes Care Applies for Health Canada Medical Device License
Feb 20, 2018
Commercial launch of the t:slim X2 Insulin Pump in Canada planned for 2H 2018 SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps, today announced its submission of a medical device license
Displaying 1 - 20 of 160